Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607828 · ClinicalTrials.gov registry record · NA
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00607828 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 7 participants.
The verdict
NCT00607828, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a phase I trial studying the side effects and best dose of stereotactic radiation therapy (SRT) in treating patients with advanced liver cancer. Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
Interventions
- RADIATION stereotactic body radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-11-16 |
| Est. Completion | 2017-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00607828
The ClinicalTrials.gov registry entry for NCT00607828 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stereotactic body radiation therapy is the first listed.
NCT00607828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00607828 about?
NCT00607828 is a clinical study titled "Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer". This is a phase I trial studying the side effects and best dose of stereotactic radiation therapy (SRT) in treating patients with advanced liver cancer. Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
What is the current status of trial NCT00607828?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2007-11-16. Estimated completion is 2017-02-15.
What interventions are being tested in trial NCT00607828?
The interventions under investigation include: stereotactic body radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00607828?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.